Nurses Protein Scientist 
XTalks
NOVEMBER 8, 2024
Top Hospital-Based Healthcare Innovations Google DeepMind AlphaFold 3: Rendering Molecules in HD Drug discovery often hinges on predicting how proteins interact with each other. The free AlphaFold Server is available to scientists globally to access high-definition molecular predictions.
pharmaphorum
NOVEMBER 2, 2020
In January, Google DeepMind debuted AlphaFold, a deep-learning system that predicts the structure of several under-studied proteins, including those associated with COVID-19. Scientists are using AI to sift through existing literature on a disease and study its disease’s structure. These chatbots can nurse and triage patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
AUGUST 25, 2021
It’s a practical tip that can be feasible for a number of people who are looking to improve their health, which is top of mind for many people,” said Yanping Li, a senior research scientist at the department of nutrition at Harvard’s T.H. Chan School of Public Health, and lead investigator of this research, in a press release.
The Pharma Data
NOVEMBER 7, 2020
Furthermore, RNA sequencing suggested that these cells may respond to the immune-related protein interferon, but more research is needed to confirm the significance. Bass , MD , and HSS scientist Laura Donlin , PhD. Flow cytometry and RNA sequencing analysis demonstrated these cells to be both cytotoxic and actively proliferating.
The Pharma Data
NOVEMBER 19, 2020
A study out of Rutgers University found that healthcare staffers, especially nurses, have a higher prevalence of COVID-19 than non-healthcare workers. Of the 40 healthcare workers who tested positive of the study group, 25 were nurses. Here’s a look at some of the more interesting ones. Healthcare Workers Most at Risk for COVID-19.
XTalks
JANUARY 5, 2021
The test identifies SARS-CoV-2 protein fragments from nasal swab samples. As a result, nurses were deployed more broadly and became more involved in supporting a study. “[It] It can also help scientists connect virtually, allowing for real-time feedback and assessments. At the same time, clinicians couldn’t get samples.
The Pharma Data
JANUARY 26, 2021
Lilly has received feedback from front-line nurses and doctors administering these infusions regarding the complexity and time requirements for preparation and administration. About bamlanivimab Bamlanivimab is a recombinant, neutralizing human IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2.
Expert insights. Personalized for you.
104 
Let's personalize your content